Discharge medication procurement and education after kidney transplantation

• Published in: Clinical transplantation Vol. 33; no. 8; pp. e13627 - n/a
• Main Authors: Potter, Lisa, Lushin, Erin N., Hofmeyer, Brooke, Ensor, Christopher, Wilson, Nikita, Tremblay, Simon, Campara, Maya
• Format: Journal Article
• Language: English
• Published: Denmark 01.08.2019
• Subjects: education; immunosuppressant; insurance; public; insurance; immunosuppressant; education; public
• ISSN: 0902-0063; 1399-0012
• DOI: 10.1111/ctr.13627

Adherence to immunosuppressant medications is a key determinant of success following organ transplantation. Medication procurement and education are precursory. In March 2018, Medicare announced a rule change interpreted to prohibit delivery of Part B‐covered immunosuppressive drugs to hospitals. A subsequent Medicare announcement clarified that immunosuppressive drug delivery to hospitals is acceptable, effective April 2019. To promulgate the perceived importance of medication delivery to hospitals among key providers of transplant discharge education, a 25‐question descriptive survey was distributed between May and July 2018 to pharmacists affiliated with each active US kidney transplant program (n = 238). Survey goals were to describe discharge medication procurement practices, discharge medication teaching practices, and attitudes toward the value of medication education. A total of 155 responses were received from 115 different transplant centers. A majority (93%) of respondents require discharge medications to be onsite prior to hospital discharge. A majority (81%) of respondents use discharge medications during medication education. Acquisition of immunosuppressant medications and their delivery to the inpatient environment prior to discharge for the purpose of medication education is a common practice, is viewed as important, and serves to enhance discharge education, ensure safe transitions of care, and encourage medication adherence.